FDA Inspection 854860 — Egis Pharmaceuticals PLC
The FDA completed an inspection of Egis Pharmaceuticals PLC on Nov 8, 2013 in Budapest. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 8, 2013
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Budapest (Hungary)